Current Assets

Trading assets

Gilead Sciences Trading assets decreased by 75.9% to $19.00M in Q3 2025 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryMarket Position
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026

How to read this metric

An increase suggests higher market-making activity or a more aggressive proprietary trading stance.

Detailed definition

These are financial instruments, such as stocks, bonds, and commodities, held by the firm for the purpose of short-term...

Peer comparison

High for investment banks and global markets divisions; lower for pure retail banks.

Metric ID: fin_trading_assets

Historical Data

10 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q2 '25Q3 '25
Value$1.69B$1.39B$1.09B$953.00M$1.01B$999.00M$1.01B$1.23B$79.00M$19.00M
QoQ Change-17.6%-21.9%-12.2%+5.8%-0.9%+0.8%+21.7%-93.6%-75.9%
YoY Change-43.5%-27.5%-8.0%+5.7%+21.6%
Range$19.00M$1.69B
CAGR-86.4%
Avg YoY Growth-10.3%
Median YoY Growth-8.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is Gilead Sciences's trading assets?
Gilead Sciences (GILD) reported trading assets of $19.00M in Q3 2025.
What does trading assets mean?
Financial assets held for the purpose of active trading and market-making.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.